Victory Capital Management Inc. Decreases Position in Stericycle, Inc. (NASDAQ:SRCL)

Victory Capital Management Inc. lessened its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL) by 6.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,942 shares of the business services provider’s stock after selling 1,165 shares during the quarter. Victory Capital Management Inc.’s holdings in Stericycle were worth $1,094,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of SRCL. Virtu Financial LLC purchased a new stake in Stericycle during the 1st quarter valued at about $209,000. Boston Partners increased its holdings in shares of Stericycle by 57.7% in the first quarter. Boston Partners now owns 15,520 shares of the business services provider’s stock valued at $819,000 after purchasing an additional 5,681 shares during the last quarter. SG Americas Securities LLC purchased a new position in Stericycle during the second quarter worth approximately $787,000. Wealth Enhancement Advisory Services LLC boosted its stake in Stericycle by 6.4% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 7,447 shares of the business services provider’s stock worth $433,000 after buying an additional 449 shares during the last quarter. Finally, Blue Trust Inc. grew its holdings in Stericycle by 19.4% in the 2nd quarter. Blue Trust Inc. now owns 4,936 shares of the business services provider’s stock valued at $287,000 after buying an additional 801 shares in the last quarter. Hedge funds and other institutional investors own 98.82% of the company’s stock.

Stericycle Stock Performance

NASDAQ SRCL opened at $61.98 on Wednesday. The stock has a fifty day simple moving average of $61.40 and a 200-day simple moving average of $58.47. The company has a current ratio of 1.20, a quick ratio of 1.13 and a debt-to-equity ratio of 0.53. The stock has a market cap of $5.75 billion, a PE ratio of 163.11, a P/E/G ratio of 3.38 and a beta of 1.10. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $61.99.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on Stericycle in a report on Wednesday, November 20th. They set a “hold” rating on the stock. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Stericycle presently has a consensus rating of “Hold” and a consensus target price of $74.00.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.